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Background

I

t may be instructive to begin this summary report and analysis
related to sustaining and realizing the promise of telemedicine
with a brief mention of its evolution and a discussion of critical
issues in its development.
The origin of telemedicine can be traced back to 1905 when the Dutch
physician, Willem Einthoven, while interested in the telephone for its
potential for measuring and recording heart sounds, demonstrated the
feasibility of telephonic transmission of heart sounds over a distance of
nearly 1 mile (1.5 km).1 Five years later, in New York City, two American
physicians successfully transmitted electrocardiograms of ventricular
hypertrophy, atrial and ventricular ectopics, and atrial and ventricular
fibrillation.2 Over the next 100 plus years, the basic concept of remote
medical care continued to evolve, although sporadically, through the
use of the telephone and two-way radio. Landmark studies using twoway television communication occurred in the mid-1950s and early
1960s. This developmental trend accelerated over the last several decades, mostly as a result of vast improvements in the capabilities of the
underlying information and communication technology (ICT), often
accompanied by a decline in cost in some of its component equipment.
Today, the feasibility of this modality of care has been investigated
in nearly all clinical specialties with the goal of ascertaining its effects on access, quality, and cost of care as well as its acceptance by
both providers and patients, while clinicians, researchers, and
product developers have expanded the scope of clinical applications
for remote diagnosis and treatment of various health problems.
Perhaps more important is that interest in telemedicine has been
maintained and continues to grow mostly as a result of the promise of
telemedicine in addressing intransigent problems in healthcare de-
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livery, including limited access to care among segments of the
population, uneven quality in the care that is generally available,
and unabated cost inflation, which stand in striking contrast with the
phenomenal progress of its underlying technology. Despite the
unprecedented promise, a long history of experimentation and development, and the ever-increasing ubiquity of the underlying technology in all sectors of modern society, the basic issues and questions
regarding the sustainability and future of telemedicine have not been
fully resolved. Among others, these issues include the precise nature of
its effects and its appropriate role in mainstream healthcare. Some
continue to question whether this modality of care is financially viable
or sustainable as currently constituted and financed. Hence, the search
continues for effective business models to sustain telemedicine’s use in
the long run by mainstream health organizations. It has been suggested
recently that a business plan for telemedicine in an academic health
center ‘‘would not be successful if it were to rely on insurance billing
alone..’’3 It would never generate sufficient revenue.
To date, it has not been determined whether telemedicine will fill
only a unique niche in the health system, namely, to serve the needs of
those who lack access by virtue of geography, isolation, or other constraints. Or, alternatively, whether telemedicine can be designed, implemented, accepted, and integrated as a necessary component of the
mainstream healthcare armamentarium—that is, integrated to the extent that medical care for the general population as well as those isolated will be provided via a combination of in-person and virtual
service. If the latter scenario holds true, both methods of care delivery
would coexist to constitute essential components of the services provided by the health system. The immediate and relevant question then
becomes the manner and means by which telemedicine can be fully
integrated into mainstream medical care and healthcare. In this context,
telemedicine will not be viewed solely as a means to extend the reach of
providers to a larger and geographically dispersed client population but
also as an essential component that enhances efficiency, assures equity
in quality of care overall, and contributes to medical cost containment.
To achieve this end, it is vital that we determine how and where to
merge certain applications such as telehome healthcare, triaging, and
electronic medical records into the medical and healthcare process
continuum. In brief, the questions must be addressed: ‘‘Is telemedicine to be viewed and incorporated merely as an adjunct or a
core feature in modern healthcare delivery?’’ ‘‘What is the optimal
role of telemedicine in medical and healthcare delivery systems?’’
‘‘How does telemedicine’s role fit into the multifocal care delivery
continuum, ranging from prevention, diagnosis, treatment, monitoring, follow-up, and end of life care?’’ If telemedicine is to become
part of mainstream medical care and healthcare, it must be adapted to
and integrated into the panoply of care locations (e.g., from private
residence to assisted living facilities, from acute and subacute care
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centers to skilled nursing centers and outpatient rehabilitation centers, from physicians’ offices to clinics [both urgent and nonurgent]
and community, regional, and major academic hospitals).
From the perspective of function, telemedicine’s role must extend
to the wide variety of clinical functions within the health system,
including clinical decision support systems, physician order entry
protocols, health information exchanges, and patient and provider
education and research. Today, these issues and questions are especially germane in the United States and in many other countries. For
example, we have yet to resolve fundamental issues regarding appropriate and equitable compensation when providers deliver care to
patients via telemedicine or in-person. Questions remain as to whether telemedicine should be restricted to a select or a specified set of
diagnostic and/or clinical services that ordinarily do not require
personal contact between patient and provider. Furthermore, if this is
the case, the appropriate and optimal diagnostic and clinical applications must be determined. This, in turn, leads to questions pertaining to optimal technological, organizational, financial, and
human resource configurations for deploying telemedicine systems.
Telemedicine constitutes a system of care embedded in and
supported by a complex information technology, which is in a
constant state of flux. As such, it also continues to evolve, undergoing significant changes and transformations related to the enabling technology and the spectrum of clinical, educational, and
research applications. In turn, these changes have varying but
significant impact on access, quality, and cost, as well as the interaction between them. One interaction in particular is the typically positive relationship between quality and cost. However, this
relationship has not been consistently demonstrated in telemedicine. Indeed, the capabilities and quality (or clinical effectiveness) of the underlying technology continue to advance at an
accelerating pace without a commensurate increase in price. Consequently, we may never be able to ascertain definitively the costeffectiveness of this electronic information technology–based care
or get a stationary assessment of its economic and clinical merit or
its ultimate contribution to society.4
After almost half a century of telemedicine proliferation, considerable evidence has been accumulated pointing to its considerable
benefits, especially those accruing to persons living in isolated areas
or institutions or those homebound and relying on biometric monitoring of physiological functioning for health maintenance. A majority of the relatively substantial amount of empirical and
experiential-based evidence pertaining to the value of telemedicine is
positive, although not necessarily definitive. This is due largely to the
fact that well-designed large-scale multi-institutional clinical trials
that could provide the definitive answers to the pertinent clinical and
economic questions have been and will likely continue to be elusive
in the foreseeable future. Alternative methodological strategies for
reaching closure on the outstanding questions have been suggested
and may be necessary, and possibly optimal.5–8
Nevertheless, there is uncontestable evidence of telemedicine’s
feasibility as a clinically effective substitute for in-person care across
an ever-increasingly wide spectrum of applications and settings.
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With respect to diagnostic accuracy, for example, there is clear evidence of the equivalence of virtual and in-person medical visits.
There also exists evidence for the added value of telemedicine providing readily available information for clinical decision making,
disease management, and provider and patient education. Much of
this evidence, however, has come in small increments, often based on
imperfect methodology.5 Nonetheless, the applications continue to
expand and proliferate, the imperfect nature of the available evidence notwithstanding.
Indeed, all things considered, it is time to identify or construct
effective business models for sustaining the current telemedicine
systems and to serve as a basis for expanding telemedicine to the next
logical level (i.e., as part of mainstream medical care and healthcare).
Ideally, these models will be based on actual experience in managing
programs successfully or, alternatively, on evidence-based links
between telemedicine interventions and specified outcomes. At a
minimum, there must be clear and explicitly identified plausible
expectations of beneficial outcomes resulting from telemedicine.
Moreover, the view of the future must be tempered by the evolving
technology within the broader context of a continual search for
enhanced access to care quality, safety assurance, and, finally, cost
containment.
At least for the foreseeable future, telemedicine in the United States
can only sustain itself on the basis of long-term business models that
rely on recurring revenue and diverse sources of financing. Yet, in the
current environment, business models that are limited to direct feefor-service reimbursement may not be sufficient to sustain telemedicine in the long term because they are severely constrained, and
we may be approaching the end of the fee-for-service method of
reimbursement. Absent a reliable recurring revenue source, business
models for telemedicine will require demonstrable evidence of benefits to patients, providers, and/or society at large to warrant an institutional and/or governmental investment in both the infrastructure
and the human resources necessary to operate the program.
With this background, it has become increasingly apparent that we
need to chart a prudent course of action regarding deployment of and
support for telemedicine systems in various states, regions, and
health systems. This needs to be viewed as part of the broader agenda
of improving access to care, enhancing quality of care, and containing cost. Case studies of several state-based and provincial-based
telemedicine programs presented in this volume describe active
networks to serve the health needs of the resident population in their
respective ‘‘telemedicine’’ regions. Some are provided in conjunction
with leading academic health centers; others provide service to
special populations such as American Indians and U.S. Army personnel and families.
It is interesting that, prior to the ICT era, the Regional Medical
Program in the United States had an auspicious beginning. However,
because of lack of continued federal support and, perhaps, lack of a
basis of integrative communication technology, it did not survive.9
Perhaps today’s tools of telemedicine could be used to revise this idea
that was ahead of its time. Given the solution of interstate licensing of
health practitioners and interinstitutional cooperation, telemedicine
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can serve as a basis for feasible and rational regionalization highly
desirable from the standpoints of access, quality, and economics. To
date, with limited exceptions, private sector interstate, regional, and,
indeed, nationally integrated health systems (i.e., those linked with
academic medical centers or centers of excellence as construed by the
original Regional Medical Program concept) remain in their infancy.
One notable exception is teleradiology, which has now developed
into not only active interstate but also international networks of
providers and users. The situation vis-à-vis interstate and national
regionalization is quite different in public sector direct service programs, for example, the U.S. Army, Veterans Administration (VA),
and the Indian Health Service (IHS). These agencies have fully embraced telemedicine as an essential component of their immense
healthcare systems to serve constituents who are geographically
dispersed throughout the country (and worldwide in the case of the
military).
Therefore, this is both an opportune and a critical time to consider
effective strategies for sustaining and realizing the promise of telemedicine in academic health centers and other provider settings in
the private sector and for integrating its tools into the mainstream
medical care and healthcare. This was the background and the rationale for organizing this symposium-workshop on the campus of
the University of Michigan. Its explicit purpose was to address the
issues pertinent to sustainability and realizing the promise of telemedicine.
As explained earlier, the symposium focused on two basic issues of
current interest. The first pertains to sustainability of telemedicine in
the current environment and the business models that have been used
to date. The second issue was the future prospect for this field, more
specifically, how to realize the promise of telemedicine more fully
than achieved thus far. Sustainability and realizing the promise of
telemedicine are logically and realistically interrelated because they
branch from the same roots, namely, the continuing problems of
limited access for variously disadvantaged segments of the population, uneven quality of care, and unabated cost inflation. To date,
these problems have defied all attempts to resolve them, while telemedicine continues to offer the lure of addressing all three problems
simultaneously.10
Based on the available evidence and using the traditional definition of this field,11 the actual use of telemedicine in the United States
today has been considerably below expectation and resource capacity. There are, however, sectors where case volume is quite high.
For example, in the VA, considering both store-and-forward and
real-time services (but not including teleradiology), about 385,000
patients were served in 2011. The VA’s electronic health record database (My HealthVet) serves more than 1 million users or 14.5% of
VA patients. During the same period, the U.S. Army reported an
estimated 60,000 individuals served via telemedicine. Additionally,
client cell phone-based medical services were also available, with
about 400,000 people currently getting medical services (e.g., telemental and behavioral health) using their cell phones. Remote
telemental health consultations, primarily involving private practitioners, provided a total of about 300,000 consultations last year. In

the federal prison system, there were about 225,000 telemedicine
visits. Finally, personal emergency response systems (which some
may not consider telemedicine but rather a remote service) have
about 1.6 million people presently subscribed—certainly not an insignificant number. With these notable exceptions (and even among
them), the potential volume of telemedicine use remains far below
expectation and capacity.
Several explanations have been suggested for the slow adoption of
telemedicine. These include insurance coverage, reimbursement, and
the convenience and availability of the technology.12 Limited or lack
of reimbursement has been identified as telemedicine’s ‘‘Gordian
knot’’ and one of the major reasons for the slow diffusion of telemedicine, hence the recent efforts regarding payment parity legislation in many states. Table 1 highlights the 12 states, covering over
106 million Americans, that have mandated telemedicine-provided
services. Table 2 highlights the six states that in 2011 had pending
legislative proposals. Similar legislation was enacted in Michigan in
2012 (House Bill 5408).
However, it should be noted that telemedicine use has been limited
even in those funded programs in which patients/clients are not required to pay for services received and providers are compensated
through project funds. In other words, it is not clear why the use of
telemedicine has fallen below expected use even in situations where
reimbursement is not a factor. Of course, when any population is
presented with an innovation that requires a radical change in behavior, there is usually a learning curve associated with adoption/
rejection of the innovation. In many instances funded projects are
ended before they reach ‘‘maturity,’’ and the acceptance–adoption

Table 1. States That Have Adopted Mandates
for Telemedicine-Provided Covered Services
STATE

YEAR OF ENACTMENT

California

1996

Colorado

2001

Georgia

2006

Hawaii

1999

Kentucky

2000

Louisiana

1995

Maine

2009

New Hampshire

2009

Oklahoma

1997

Oregon

2009

Texas

1997

Virginia

2010

Michigan

2012
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Table 2. States with Pending Legislation
STATE

LEGISLATIVE STATUS

Florida

S.B. 1842, H.B. 60

Maryland

S.B. 298, S.B. 744, H.B. 14

New Mexico

H.B. 591

Ohio

S.B. 280

Pennsylvania

H.B. 273

Vermont

H.B. 37

Source: www.americantelemed.org/files/public/Meetings/PolicySummit2011/
StateMandate.pdf
H.B., House Bill, S.B., Senate Bill.

process by the target population, including physicians, cannot be
completed.
Teleradiology programs are one exception. Among telemedicine
applications to date, they have demonstrably experienced the
greatest degree of acceptance and proliferation. Some of the key
reasons behind this level of success include (1) the fact that the
majority of radiologic services (excluding interventional) rarely include face-to-face interaction between the radiologist and the patient, (2) the early creation of a communications standard the Digital
Imaging and Communications in Medicine (DICOM) standard (http://
medical.nema.org/)) that facilitated system interoperability across
vendors and institutions, (3) ready reimbursement approval by the
Health Care Financing Administration in large part due to the previous two factors, and (4) the fact that the majority of technology
used in digital radiology and thus teleradiology were Food and Drug
Administration–approved devices.
A broader question pertains to the disjuncture between capacity
and volume of use. The capacity for telemedicine technology far
exceeds actual use. When properly designed and implemented, the
vast majority of extant programs have the potential to serve much
larger patient populations. As well, again, if properly designed and
implemented, the enabling technology can arguably enhance productivity and capacity well beyond current levels. Nevertheless, some
evidence suggests that, in some instances, telemedicine encounters
are more time consuming than in-person consults. In these instances,
this adversely affects provider productivity and therefore makes it
difficult to assess accurately total resource capacity. It is also difficult
to measure the precise impact on productivity because of the complex
combination of human resources (doctors, nurses, etc.), equipment,
and connectivity in play. Be this as it may, once the supporting
technology is in place, a much larger and widely distributed patient
population can be served by telemedicine than in the traditional inperson consult. Moreover, in addition to forward movement along
the learning curve by providers, there are operational processes to
increase efficiency and productivity, such as scheduling blocks of
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clinic time rather than offering the service on ‘‘as requested’’ basis.
Ceteris paribus, we can expect a substantial lag between the capabilities of telemedicine technologies and our ability to exploit these
capabilities. Although we may never match use with capacity, there is
considerable impetus to improve the ratio. This is especially true at
this time when the United States and countries around the world are
struggling with budget deficits in which spending on healthcare
comprises a significant drain on the federal revenues.

Sustainability of Telemedicine
Certainly, sustainability in healthcare, as for any self-supporting
enterprise or service delivery system, depends primarily on recurring
revenue. However, return on investment can be thought of broadly or
narrowly. It can take different forms and can be direct or indirect,
immediate or delayed, tangible or intangible. Regardless of the form
recurring revenue takes, it must occur and must be of sufficient size
or accrued value if the enterprise is to remain solvent over the long
term. Indeed, should recurring revenue be inadequate, the enterprise
must make structural adjustments. These include reducing the size
and/or scope of service or improving its mode of production. When
revenues or derived value in the form of an indirect return on investment cannot be sustained, the organization must find ways to
reduce expenditures in order to maintain its financial integrity or
otherwise cease to exist in its present form.
To date, the majority of private sector telemedicine programs in
the United States have relied heavily on non-recurring extramural
funding or other provisions or appropriations from state and/or
federal sources. Grants have come in different forms, including line
items (set-aside funds) in state or federal budgets or as successful bids
in competitive solicitations. Regardless of form, these agency funds
have been instrumental in establishing telemedicine programs during
the ‘‘maturation period’’ of telemedicine and beyond, particularly in
the initial stages of development and in some instances sustaining
them beyond the initial funding period. Moreover, the use of these
funds enabled some programs to demonstrate the benefits of telemedicine to policymakers and third-party payers. Furthermore, they
have also served as fertile grounds for gathering useful information
about the feasibility, effects, and acceptance of telemedicine. Nonetheless, agency grants and funding offer only temporary support, and
they can never serve as effective substitutes for recurring revenue.
This is not meant to belittle the impact of granting agency funding,
for this funding of telemedicine over the last two decades has been
substantial and vital. It served to create a critical mass of programs
across the United States, which in turn have supported development
of telemedicine applications and practitioners across almost the entire spectrum of clinical care. Additionally, the funding generated a
generation of system development specialists and a proliferation of
telemedicine vendors. This critical mass of gatekeepers now advocate
actively for the wider adoption of favorable policies to advance the
practice of telemedicine at local, state, and national levels. Their
advocacy has proven effective in reducing barriers to reimbursement
for telemedicine consultations and interstate licensure and practice.
The growth in telemedicine is reflected in the growth of the
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American Telemedicine Association (ATA). The ATA was established
in 1993 as a nonprofit organization headquartered in Washington,
DC. Although originally organized as an ‘‘American’’ association, the
ATA now has two international regional chapters (Pacific Islands and
Latin-American & Caribbean Chapters) and a membership distributed
across 45 countries. The ATA has also signed membership-based
agreements with eight other countries.

Sustainability Perspectives
Analysis of the sustainability of telemedicine as a system or modality of care can be considered from several perspectives. Each
represents an informed viewpoint developed to ascertain or establish
a basis for operational continuity in a specific health system, whether
private or public. A health system may adopt one or more of these
perspectives, as befitting its institutional mission, goals and objectives, and strategic plans. This is especially the case for those with
relationships to the larger community of patients and other providers
in their respective spheres. These perspectives include telemedicine as
a mainstream service, gateway to the institution, and intra- or intercommunity or state/federal resource.

TELEMEDICINE AS A MAINSTREAM SERVICE
As stated earlier, the telemedicine proponents’ view of telemedicine is one of a mainstream service fully integrated into the
institutional portfolio of services provided by the health system.
Ideally, under this scenario, telemedicine services would be reimbursed under the prevailing payment system utilizing service
charge codes similar to those for in-person care. The indirect cost
involving the purchase and maintenance of the infrastructure
would be absorbed by the institution. Recurring revenue would occur
in one or a combination of several forms, including reimbursement per unit of service or contractual agreements/partnerships with
global budgeting for blocks of service. Even in such an ‘‘ideal world,’’
telemedicine would be viewed as a mainstream service only when it is
supported by a payment system that does not impose severe constraints on the direct reimbursement for care when rendered ‘‘virtually’’ via ICT.

TELEMEDICINE AS A GATEWAY TO THE INSTITUTION
Absent direct recurring revenue, the provision of telemedicine
services may be viewed as a gateway to the institution that has a
potential for delayed or latent sources of income. In this case, sustainability can derive from downstream revenue through increased
appropriate referrals, that is, patients requiring more specialized,
high-intensity services. Additionally, patients with more favorable
health insurance coverage, including self-insured patients, can be
attracted from a much wider geographic area. From a management
standpoint, this perspective requires detailed documentation to
provide evidence of deferred revenue that can be attributed to telemedicine interventions. The documentation would also include offsite triage of patients for efficient referral to specialty or emergency
services.

TELEMEDICINE AS AN INTRASTATE COMMUNITY
OR INTERSTATE REGIONAL RESOURCE
When neither direct nor delayed recurring reimbursement is
possible, it becomes difficult to sustain a telemedicine program for an
appreciable period of time absent dedicated extramural funding.
Hence, a third perspective would consist of considering and developing telemedicine services as an intrastate community or interstate
regional resource network to support remote providers. From this
perspective, the investment in the infrastructure can be considered an
essential utility in the broader health system of the state, the region,
or the nation. Sustainability would be achieved by a broad-based
governmental or health system constituency and increased efficiency, effectiveness, and system integration.

The Promise of Telemedicine
The promise of telemedicine rests on the three pillars of care,
namely, improved access, enhanced quality, and cost containment.
This daunting promise contains an imposing challenge that will be
difficult to meet. Nonetheless, this is the task at hand. We cannot nor
should we hesitate in proceeding. To do this, as a first step, we must
identify and define the specific telemedicine modalities both necessary and appropriate to meet these challenges and thus fulfill each of
these promises. Subsequently we must determine the processes to
implement and sustain them.

ACCESS
In assessing the effects of telemedicine on access to care, we need
to develop the following:
.

.

An explicit understanding, in realistic and feasible terms, of the
manner in which telemedicine contributes to the full spectrum
of access, including avoiding unnecessary travel, spatial–
temporal, and economic aspects, and opportunity cost.
A clear definition of the manner in which telemedicine improves the linkages between use of service and need for service.
This entails an empirical analysis of the location of need, the
location of resources to satisfy that need, and how telemedicine
provides the linkages between them.

QUALITY
When considering quality, we need:
.

.

Professional performance standards based upon the research
findings pertaining to the practice of evidence-based medicine
from tertiary-care centers to individual practitioners. At the
same time, it must be acknowledged that today much if not
most medical care is not evidence-based, and therefore performance standards developed for telemedicine may, in fact,
be disseminated to and therefore improve medical care in
general.
A clear definition of the specific role and contributions of telemedicine to the practice of evidence-based medicine across the
continuum of patient-centered care.
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.

.

An explicit understanding of the specific mechanisms by which
telemedicine contributes to optimal quality of care not only for
the individual but also for population groups and communities.
In the latter instance, we need to demonstrate the potential
contributions of telemedicine to achieving optimal health status
in the community. This implies an inclusive focus on a continuum of care management focused on patients rather than
diseases, ranging from preventative services to therapeutic and
rehabilitative services to humane and dignified end-of-life
support strategies.
Beyond these, it would also entail a realistic analysis of how
telemedicine can encourage appropriate use of services and
discourage inappropriate use of services. To be sure, this is
made somewhat more difficult because of the lack of clear and
universally accepted definitions of what is acceptable for each
application. The optimal applications of telemedicine would
support and enable the provision of appropriate level and intensity of care at the point of need by appropriate providers in
an appropriate site or setting.

COST CONTAINMENT
And, finally, when considering cost containment, we need:
.

.

.

A comprehensive definition of cost containment in real terms
over and beyond reductions in opportunity cost for patients
and/or providers. This definition must not be limited to obviating or reducing the need for travel for patients and/or
providers.
A clear understanding of the specific processes by which telemedicine would reduce redundancy and waste of resources and
reduce intensity of care while minimizing adverse events. Perhaps, most importantly, we need to learn how to create effective
substitutions, whereby less costly interventions will produce
similar health outcomes (i.e., lower-cost substitutes without
infringing on quality).
Explicit triage algorithms at the remote sites (or those requesting service or information) would establish protocols for
second opinion, referral, or transfer as indicated by clinical
need and the availability of appropriate resources at the local or
regional level. This would require uniform personal health records accessible at all sites of care.

Concluding Remarks
Attempts to address the seemingly intransigent problems pertaining to inequitable access to healthcare and differential quality in
available care can be traced back to the mid-19th century in the
United States and even earlier in Europe. To this must be added the
more recent problem of the unabated inflation in the cost of medical
care that has continued since the mid-20th century. It is against this
backdrop and within this context that telemedicine has emerged, and
proponents have argued that it holds the promise of improving access
to healthcare, while enhancing quality of care and restraining cost
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inflation. Despite these promises, basic questions persist as to how to
sustain telemedicine and how to realize its promise.
A careful review of articles presented in this issue of the Journal
reveals a set of creative business strategies and, in some cases, the
serendipitous circumstances that led to the initial start-up of now
well-established telemedicine academic medical center programs.
These strategies include (1) securing start-up as well as competitive
grants and ‘‘set-aside’’ line items in federal and state agency budgets,
(2) state advocacy (and some at the national level) to enact laws
aimed at removing reimbursement barriers for telemedicine services,
(3) direct state sponsorship of programs, (4) institutional funding, (5)
membership fees from participating sites, and (6) private donations.
Indeed, the most successful programs have relied on a combination of
all the above.
This scenario contrasts sharply with those described in articles
pertaining to telemedicine programs in direct delivery systems, such
as the VA, the U.S. Army, and the IHS. In these instances, financial
support for telemedicine is provided in measured response to a perceived and real need to deliver quality care for large and geographically dispersed target populations. The users (both patients and
providers) and the specific applications are clearly identified. Hence,
the benefits to the health system (or return on investment) are usually
demonstrable in some form, such as saved lives, cost efficiencies, etc.
These telemedicine programs are implemented on a regional, national, and/or global basis. Even given the vagaries of funding cycles
from one Congress to another, funding for these telemedicine programs seems to be secure. However, complications can arise. In the
case of the IHS, for example, federal laws pertaining to Tribal control
of federal funding for healthcare as well as cultural differences in
terms of ‘‘appropriate’’ forms of medical care have created obstacles
to ubiquitous implementation of telemedicine for the American
Indian and Alaskan Native populations.
The Canadian example, represented here by the Ontario Telemedicine Network, is singular in that it describes a setting where
governments at the federal and provincial levels recognize the merit
of telemedicine in expanding access to quality healthcare in the
private sector in an efficient manner. In this instance, the government
is a single payer for a federally tax-supported, inclusive healthcare
system.
In the future, sustaining telemedicine and, importantly, seeing it
become an integral component of mainstream healthcare will come
to fruition through the combination of developing and adopting
business plans assuring stable recurring revenues, regardless of form
or source. The latter include one or a combination of funds, derived
from telemedicine, as a gateway to the institution, intra- and intercommunity, or federal resources. To the extent that previous experience informs, it appears that a single-payer, federally funded public
healthcare system provides an optimal scenario for telemedicine
becoming both sustainable and an integral component of mainstream
healthcare.
In the absence of this, however, the promise of telemedicine relies
on understanding telemedicine’s contribution to the full spectrum of
care and the manner in which it enables an appropriate balance
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between the need for and use of care. The degree to which telemedicine favorably influences quality of care through the provision
of evidence-based care must be assessed and demonstrated. Finally,
telemedicine’s economic implications must be evaluated comprehensively, that is, beyond reduction of opportunity costs for patients
and providers. The economic analysis must be expanded to include
telemedicine’s effects on reducing, if not eliminating, redundancy
and waste of resources, improving provider productivity, and enhancing on-site triage for patients as well as the application of appropriate protocols and intensity of care at the appropriate site. It is to
these ends that the symposium ‘‘Sustaining and Realizing the Promise
of Telemedicine’’ was convened and that this special issue of the
Telemedicine and e-Health Journal is presented.
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